Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells

Circulation

Volumn 98, Issue 12, 1998, Pages 1212-1218

  Iwashina, Masatora ^a   Shichiri, Masayoshi ^a   Marumo, Fumiaki ^a   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Atherosclerosis; Endothelium derived factors; Genes; Vasculature

Indexed keywords

BIOTIN; COMPLEMENTARY DNA; DNA FRAGMENT; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; TUMOR SUPPRESSOR GENE; VASCULAR SMOOTH MUSCLE;

EID: 0032558414     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.12.1212     Document Type: Article

References (36)

1. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051-3064.
2. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
3. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol. 1993;150: 5080-5085.
4. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 1996; 10:1-15.
5. Collins MK, Lopez RA. The control of apoptosis in mammalian cells. Trends Biochem Sci. 1993;18:307-309.
6. Nicotera P, Brune B, Bagetta G. Nitric oxide: inducer or suppressor of apoptosis? Trends Pharmacol Sci. 1997;18:189-190.
7. Sato I, Kaji K, Murota S. Age related decline in cytokine induced nitric oxide synthase activation and apoptosis in cultured endothelial cells: minimal involvement of nitric oxide in the apoptosis. Mech Ageing Dev. 1995;81:27-36.
8. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res. 1996;79:748-756.
9. Fukuo K, Hata S, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y, Morimoto S, Ogihara T. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension. 1996;27:823-826.
10. Bochaton PM, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 1995;146:1059-1064.
11. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 1990; 4:2860-2867.
12. Hirata Y, Yoshimi H, Takaichi S, Yanagisawa M, Masaki T. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett. 1988;239:13-17.
13. Iwashina M, Hirata Y, Imai T, Sato K, Marumo F. Molecular cloning of endothelial, inducible nitric oxide synthase gene from rat aortic endothelial cell. Eur J Biochem. 1996;237:668-673.
14. Takebe Y, Seiki M, Fujisawa J, Hoy P, Yokota K, Arai K, Yoshida M, Arai N. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol. 1988;8:466-472.
15. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, Marumo F. L-arginine infusion induces hypotension and increases diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in human. Clin Exp Pharmacol Physiol. 1992;19:619-625.
16. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 1990;347:768-770.
17. Shichiri M, Sedivy JM, Marumo F, Hirata Y. Endothelin is a potent survival factor for c-myc-dependent apoptosis. Mol Endocrinol. 1998;12: 172-180.
18. Herrmann Ç, Lorenz HM, Voll R, Grunke M, Woith W, Kalden JR. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 1994;22:5506-5507.
19. Shichiri M, Kato H, Marumo F, Hirata Y. Endothelin-1 as an autocrine/ paracrine apoptosis survival factor for endothelial cells. Hypertension. 1997;30:1198-1203.
20. Shichiri M, Hanson KD, Sedivy JM. Effects of c-myc expression on proliferation, quiescence, and the G0 to G1 transition in nontransformed cells. Cell Growth Differ. 1993;4:93-104.
21. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1774-1777.
22. Kariya K, Kawahara Y, Araki S, Fukuzaki H, Takai Y. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis. 1989;80:143-147.
23. Higuchi M, Singh S, Jaffrezou JP, Aggarwal BB. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation. J Immunol. 1996;157:297-304.
24. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell. 1995;81: 495-504.
25. Ioannidis I, Batz M, Paul T, Korth HG, Sustmann R, De GH. Enhanced release of nitric oxide causes increased cytotoxicity of S-nitroso-N-acetyl-DL-penicillamine and sodium nitroprusside under hypoxic conditions. Biochem J. 1996;318:789-795.
26. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 1991;254:1001-1003.
27. Gorsdorf S, Appel KE, Engeholm C, Obe G. Nitrogen dioxide induces DNA single-strand breaks in cultured Chinese hamster cells. Carcinogenesis. 1990;11:37-41.
28. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 1988;27:8706-8711.
29. Szabo C. DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic Biol Med. 1996;21:855-869.
30. Sinkovics J, Horvath J. Apoptosis by genetic engineering. Leukemia. 1994;8:S98-S102.
31. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
32. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
33. Lane DP. Cancer. p53: guardian of the genome. Nature. 1992;358:15-16.
34. Leyen H, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995;92:1137-1141.
35. Hansson GK, Geng YJ, Holm J, Hardhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med. 1994;180:733-738.
36. Yan ZQ, Yokota T, Zhang W, Hansson GK. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res. 1996;79:38-44.